Innova Captab Limited (BOM:544067)
862.30
-9.45 (-1.08%)
At close: Jun 5, 2026
Innova Captab Revenue
In the fiscal year ending March 31, 2026, Innova Captab had annual revenue of 16.30B INR with 31.06% growth. Innova Captab had revenue of 4.48B in the quarter ending March 31, 2026, with 42.28% growth.
Revenue
16.30B
Revenue Growth
+31.06%
P/S Ratio
3.05
Revenue / Employee
10.19M
Employees
1,600
Market Cap
49.64B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 16.30B | 3.86B | 31.06% |
| Mar 31, 2025 | 12.44B | 1.62B | 15.02% |
| Mar 31, 2024 | 10.81B | 1.55B | 16.72% |
| Mar 31, 2023 | 9.26B | 1.26B | 15.72% |
| Mar 31, 2022 | 8.01B | 3.90B | 94.94% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Unichem Laboratories | 22.65B |
| FDC Limited | 21.71B |
| Morepen Laboratories | 18.06B |
| Sanofi India | 17.74B |
| Hikal | 17.13B |
| Procter & Gamble Health | 14.08B |
| CORONA Remedies | 14.03B |
| Gufic Biosciences | 9.47B |